Oppenheimer & Co’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,342
Closed -$144K 1603
2024
Q3
$144K Sell
15,342
-566
-4% -$5.36K ﹤0.01% 1437
2024
Q2
$128K Sell
15,908
-717
-4% -$7.68K ﹤0.01% 1375
2024
Q1
$246K Buy
+16,625
New +$194K ﹤0.01% 1252
2022
Q2
Sell
-10,196
Closed -$170K 1475
2022
Q1
$170K Sell
10,196
-1,671
-14% -$25.8K ﹤0.01% 1378
2021
Q4
$227K Sell
11,867
-3,587
-23% -$79K ﹤0.01% 1346
2021
Q3
$381K Buy
15,454
+115
+0.7% +$2.71K 0.01% 1125
2021
Q2
$399K Sell
15,339
-1,348
-8% -$35K 0.01% 1117
2021
Q1
$528K Sell
16,687
-2,389
-13% -$99K 0.01% 943
2020
Q4
$885K Sell
19,076
-4,690
-20% -$186K 0.02% 689
2020
Q3
$783K Buy
23,766
+3,744
+19% +$115K 0.02% 668
2020
Q2
$549K Buy
+20,022
New +$658K 0.01% 774

Other funds holding IOVA